{"gene":"APBA2","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1999,"finding":"Mint2/X11L colocalizes with APP in primary cortical neurons and transfected CHO cells; Mint2 reorganizes the subcellular distribution of APP and increases steady-state APP levels when co-expressed, consistent with a role in APP trafficking and metabolism.","method":"Immunofluorescence colocalization in primary neurons and transfected CHO cells; co-transfection with subcellular distribution analysis","journal":"The European journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, colocalization and co-transfection with distribution assay, no in vitro reconstitution","pmids":["10336668"],"is_preprint":false},{"year":2000,"finding":"XB51, a novel protein, interacts with the amino-terminal domain of X11L (APBA2/Mint2), inhibits the X11L–APP association through a non-competitive mechanism, and abolishes X11L-mediated suppression of beta-amyloid production. Association with X11L redistributes XB51 from a CHAPS-insoluble to a CHAPS-soluble fraction.","method":"Yeast two-hybrid screening, co-immunoprecipitation, beta-amyloid production assay, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, functional Aβ assay, and fractionation in a single lab","pmids":["10833507"],"is_preprint":false},{"year":2003,"finding":"hXB51alpha binds X11L to form a tripartite complex (hXB51alpha–X11L–APP) that blocks X11L-mediated suppression of Aβ generation, while hXB51beta binds X11L and inhibits its interaction with APP but suppresses Aβ generation via an X11L-independent mechanism.","method":"Co-immunoprecipitation, Aβ production assays, isoform-specific expression constructs","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with functional Aβ assay, single lab, two isoforms tested orthogonally","pmids":["12780348"],"is_preprint":false},{"year":2004,"finding":"X11L (APBA2/Mint2) facilitates JNK-mediated phosphorylation of APP at Thr668 and APLP2 at Thr736 in response to cellular stress, elevating phosphorylation levels. Other X11 family members (X11 and X11L2) did not share this activity.","method":"Cell-based phosphorylation assays under osmotic/stress conditions, immunoprecipitation, kinase identification","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional phosphorylation assay with multiple substrates and family-member comparisons, single lab","pmids":["14970211"],"is_preprint":false},{"year":2006,"finding":"X11L-deficient (knockout) mice show increased APP C-terminal fragments generated by β-secretase (but not α-secretase) cleavage in the hippocampus, and elevated Aβ levels in aged hippocampus, demonstrating that X11L suppresses amyloidogenic (but not non-amyloidogenic) APP processing in vivo.","method":"X11L knockout mouse model, biochemical quantification of APP CTFs and Aβ levels in brain tissue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined molecular phenotype (selective β-secretase pathway), in vivo replicated finding in brain tissue","pmids":["17032642"],"is_preprint":false},{"year":2007,"finding":"X11L (APBA2) and X11L2 shuttle between the cytoplasm and nucleus; nuclear export is CRM1-dependent (blocked by leptomycin B). FLIP analysis confirmed nucleo-cytoplasmic shuttling. A nuclear export signal (NES) was identified in the N-terminus of X11L2; mutation of this NES caused nuclear accumulation.","method":"EGFP-fusion localization, leptomycin B treatment, FLIP (fluorescence loss in photobleaching), NES mutagenesis","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging with FLIP and pharmacological/mutagenesis validation, single lab","pmids":["18201694"],"is_preprint":false},{"year":2009,"finding":"Phosphorylation of X11L at Ser236 and Ser238 within the amino-terminal regulatory region (aa 221–250) enhances its interaction with APP under osmotic stress. Alanyl substitution of either serine abolished the stress-enhanced APP association, indicating that this phosphorylation event, outside the PTB domain, modulates APP binding.","method":"Site-directed mutagenesis (Ser→Ala), co-immunoprecipitation under osmotic stress, phosphorylation site identification by mass spectrometry/mutagenesis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with co-IP functional assay, single lab","pmids":["19222704"],"is_preprint":false},{"year":2009,"finding":"Mint2 interacts with TrkA through its PTB domain in a phosphorylation- and ligand-independent manner. Endogenous Mint2–TrkA interaction was confirmed in rat tissue. Mint2 overexpression inhibited NGF-induced neurite outgrowth in PC12 cells and DRG neurons; Mint2 knockdown facilitated it. Mechanistically, Mint2 promotes TrkA retention in the Golgi, inhibiting surface sorting.","method":"Yeast two-hybrid screening, co-immunoprecipitation from rat tissue, immunohistochemistry colocalization, overexpression and siRNA knockdown in PC12 and DRG neurons, Golgi retention assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP in endogenous tissue, gain- and loss-of-function with defined cellular phenotype, Golgi trafficking mechanism, multiple orthogonal methods","pmids":["19265194"],"is_preprint":false},{"year":2012,"finding":"Crystal structures of APP peptide-free (2.7 Å) and APP peptide-bound (3.3 Å) Mint2 C-terminal mutants revealed that the ARM domain blocks the PTB domain peptide-binding groove in the closed (unbound) state and swings away in the open (APP-bound) state. Mutants locking Mint2 in open or closed conformations dynamically regulated APP metabolism in vitro and in vivo.","method":"X-ray crystallography, structure-guided mutagenesis, in vitro APP metabolism assays, in vivo mouse model","journal":"Journal of molecular cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures at near-atomic resolution combined with mutagenesis and both in vitro and in vivo functional validation","pmids":["22730553"],"is_preprint":false},{"year":2012,"finding":"Src-mediated phosphorylation of Mint2 regulates APP endocytic sorting: a phosphomimetic Mint2 mutant directed internalized APP toward the autophagic pathway and increased intracellular Aβ accumulation, while the phospho-resistant mutant increased APP recycling to the cell surface and enhanced Aβ42 secretion. APP endocytosis was attenuated in Mint knockout neurons.","method":"Mint knockout neurons (endocytosis assay), phosphomimetic/phospho-resistant Mint2 mutants, intracellular trafficking pathway analysis, Aβ measurement","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout plus phosphorylation-site mutagenesis with defined trafficking and Aβ phenotypes, multiple orthogonal approaches","pmids":["22787047"],"is_preprint":false},{"year":2018,"finding":"Systematic characterization of the Mint2 protein-protein interaction network showed that APP and presenilin-1 are bona fide Mint2 interaction partners with defined domain specificities. The last two C-terminal amino acids of Mint2 are required for the intramolecular PDZ1 interaction and for Mint2 stability.","method":"Peptide binding assays, domain-specific interaction mapping, truncation/deletion analysis","journal":"Chembiochem","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — systematic PPI mapping with domain specificity data, single lab, biochemical assays","pmids":["29578633"],"is_preprint":false},{"year":2019,"finding":"The autism-linked Mint2 N723S mutation (in PDZ2 domain) impairs Nrxn1α stabilization and trafficking to the membrane without affecting direct Nrxn1α binding. The mutant caused more immobile Mint2 puncta in neuronal processes, reduced Nrxn1α at presynaptic terminals, decreased Nrxn-mediated synaptogenesis, and reduced miniature excitatory event frequency.","method":"Mutation of conserved PDZ2 residue, time-lapse imaging in primary mouse neurons, surface biotinylation/trafficking assays, synaptogenesis assay, electrophysiology (mEPSC recording)","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (imaging, trafficking, synaptogenesis, electrophysiology) in a single study, autism-linked mutation functionally validated","pmids":["30988517"],"is_preprint":false},{"year":2021,"finding":"Disruption of the APP–Mint2 protein-protein interaction, either by an APP-binding-deficient Mint2 variant or by a cell-permeable peptide inhibitor targeting the Mint2 PTB domain, significantly reduced Aβ42 levels in a neuronal in vitro AD model, demonstrating that Mint2 plays a facilitative role in Aβ formation.","method":"APP-binding-deficient Mint2 mutant, cell-permeable PPI inhibitor peptide, Aβ42 ELISA in neuronal AD model cells","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complementary genetic and pharmacological inhibition with defined Aβ readout, single lab","pmids":["33398998"],"is_preprint":false},{"year":2007,"finding":"Mint proteins (Mint1 and Mint2) are cleaved by calpain upon neurodegeneration induced by okadaic acid (a PP2A inhibitor) in neurons, and their reduction is followed by an increase in APP levels. Calpain inhibitors prevented Mint cleavage and APP overexpression.","method":"Okadaic acid neuronal degeneration model, western blot for Mint1/2 and APP, calpain inhibitor treatment","journal":"Neuroreport","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single biochemical method with pharmacological inhibitor, limited mechanistic depth","pmids":["18007179"],"is_preprint":false}],"current_model":"APBA2/Mint2/X11L is a neuronal adaptor protein that binds the cytoplasmic domain of APP via its PTB domain (regulated by an ARM-domain open-closed conformational switch and by Ser236/238 phosphorylation), suppresses amyloidogenic β-secretase cleavage of APP in the hippocampus in vivo, and controls APP endocytic sorting between autophagic and recycling pathways through Src-mediated phosphorylation; it also traffics neurexin-1α to presynaptic terminals via its PDZ2 domain (disrupted by autism-linked N723S mutation), retains TrkA in the Golgi to modulate NGF-induced neurite outgrowth, and is regulated by the binding partner XB51 which can either block or enhance Aβ production depending on its isoform."},"narrative":{"mechanistic_narrative":"APBA2 (Mint2/X11L) is a neuronal adaptor protein that controls the trafficking and proteolytic processing of the amyloid precursor protein (APP) and other transmembrane partners [PMID:10336668, PMID:17032642]. It binds the APP cytoplasmic domain through its PTB domain, an interaction gated by an autoinhibitory ARM domain that occludes the PTB peptide-binding groove in a closed state and swings away upon APP engagement, allowing conformational locking to bidirectionally tune APP metabolism [PMID:22730553]; APP binding is further enhanced by phosphorylation at Ser236/Ser238 in an N-terminal regulatory region under stress [PMID:19222704]. In vivo, loss of APBA2 selectively increases β-secretase-derived APP C-terminal fragments and Aβ in hippocampus, establishing it as a suppressor of amyloidogenic processing [PMID:17032642], while at the cellular level Src-mediated phosphorylation of Mint2 directs internalized APP between autophagic degradation and surface recycling, with corresponding shifts in Aβ production [PMID:22787047]. APBA2 also acts as a presynaptic trafficking factor: through its PDZ2 domain it stabilizes and delivers neurexin-1α to presynaptic terminals, and the autism-linked N723S mutation disrupts this without abolishing direct binding, reducing synaptogenesis and excitatory transmission [PMID:30988517]. Independently, through its PTB domain it retains TrkA in the Golgi to restrain NGF-induced neurite outgrowth [PMID:19265194]. Its APP-suppressive activity is itself regulated by the binding partner XB51, whose isoforms either block or enhance Aβ generation [PMID:10833507, PMID:12780348].","teleology":[{"year":1999,"claim":"Established APBA2/Mint2 as a physical and functional regulator of APP rather than an unrelated neuronal protein, by showing it colocalizes with APP and reshapes its distribution and steady-state levels.","evidence":"Immunofluorescence colocalization and co-transfection distribution analysis in primary neurons and CHO cells","pmids":["10336668"],"confidence":"Medium","gaps":["Did not define the binding interface or domain","Effect on APP cleavage products not measured","No in vivo confirmation"]},{"year":2000,"claim":"Identified XB51 as an upstream regulator of the Mint2–APP axis, showing that the amyloid-suppressing activity of Mint2 is itself modulated by a binding partner.","evidence":"Yeast two-hybrid, reciprocal co-IP, Aβ production assay, and subcellular fractionation","pmids":["10833507"],"confidence":"Medium","gaps":["Non-competitive inhibition mechanism not structurally defined","Physiological relevance not tested in vivo"]},{"year":2003,"claim":"Resolved that XB51 effects on Aβ are isoform-specific, with hXB51alpha forming a tripartite complex that blocks Mint2 suppression while hXB51beta lowers Aβ by a Mint2-independent route.","evidence":"Co-IP and Aβ assays with isoform-specific constructs","pmids":["12780348"],"confidence":"Medium","gaps":["Mint2-independent mechanism of hXB51beta undefined","No structural basis for tripartite complex"]},{"year":2004,"claim":"Showed Mint2 has a kinase-coupling function specific among X11 family members, facilitating JNK-mediated phosphorylation of APP/APLP2 under stress.","evidence":"Cell-based stress phosphorylation assays with family-member comparison","pmids":["14970211"],"confidence":"Medium","gaps":["Direct vs scaffolded JNK action not separated","Downstream consequence of Thr668 phosphorylation on Aβ not established here"]},{"year":2006,"claim":"Provided the decisive in vivo demonstration that APBA2 selectively suppresses amyloidogenic APP processing, by showing knockout mice accumulate β-secretase CTFs and Aβ in hippocampus.","evidence":"X11L knockout mouse with biochemical quantification of APP CTFs and Aβ in brain","pmids":["17032642"],"confidence":"High","gaps":["Mechanism of pathway selectivity (β vs α) not resolved","Cellular trafficking basis not addressed"]},{"year":2007,"claim":"Revealed APBA2 undergoes CRM1-dependent nucleo-cytoplasmic shuttling, expanding its potential roles beyond cytoplasmic trafficking.","evidence":"EGFP-fusion imaging, leptomycin B, FLIP, and NES mutagenesis","pmids":["18201694"],"confidence":"Medium","gaps":["Nuclear function of Mint2 unknown","NES mapped directly only for X11L2"]},{"year":2007,"claim":"Connected Mint2 levels to neurodegeneration by showing calpain cleaves it, with consequent APP elevation.","evidence":"Okadaic acid degeneration model with western blot and calpain inhibitor","pmids":["18007179"],"confidence":"Low","gaps":["Single biochemical method with pharmacological inhibitor","Calpain cleavage sites not mapped","Causality between Mint loss and APP rise not isolated"]},{"year":2009,"claim":"Defined a stress-responsive phospho-switch (Ser236/Ser238) outside the PTB domain that tunes Mint2–APP binding strength.","evidence":"Ser→Ala mutagenesis with co-IP under osmotic stress","pmids":["19222704"],"confidence":"Medium","gaps":["Responsible kinase not identified","In vivo relevance of these sites untested"]},{"year":2009,"claim":"Extended Mint2 function beyond APP, showing it retains TrkA in the Golgi via its PTB domain to negatively regulate NGF-induced neurite outgrowth.","evidence":"Yeast two-hybrid, endogenous reciprocal co-IP, gain/loss-of-function in PC12 and DRG neurons, Golgi retention assay","pmids":["19265194"],"confidence":"High","gaps":["How a single PTB domain selects APP vs TrkA cargo unclear","In vivo neurite/NGF phenotype not shown"]},{"year":2012,"claim":"Provided the structural mechanism of Mint2 autoregulation: an ARM domain occludes the PTB groove in a closed state and releases it on APP binding, with conformation-locked mutants bidirectionally controlling APP metabolism.","evidence":"X-ray crystallography of free and APP-bound mutants with structure-guided mutagenesis in vitro and in vivo","pmids":["22730553"],"confidence":"High","gaps":["Trigger that drives the open–closed switch in cells not defined","Relationship of switch to Ser236/238 phosphorylation not integrated"]},{"year":2012,"claim":"Showed Src-mediated phosphorylation of Mint2 acts as a sorting switch routing internalized APP between autophagic degradation and recycling, directly coupling Mint2 to Aβ fate.","evidence":"Mint knockout neurons, phosphomimetic and phospho-resistant mutants, trafficking analysis, Aβ measurement","pmids":["22787047"],"confidence":"High","gaps":["Src phosphorylation site(s) on Mint2 not fully mapped","Reconciliation with in vivo β-secretase suppression role incomplete"]},{"year":2018,"claim":"Systematically validated APP and presenilin-1 as domain-specific Mint2 partners and showed the C-terminal residues mediate an intramolecular PDZ1 interaction governing Mint2 stability.","evidence":"Peptide binding and domain-mapping with truncation analysis","pmids":["29578633"],"confidence":"Medium","gaps":["Functional consequence of presenilin-1 binding not tested","Stability mechanism not linked to turnover in cells"]},{"year":2019,"claim":"Linked APBA2 directly to autism pathophysiology by showing the PDZ2 N723S mutation impairs neurexin-1α trafficking, synaptogenesis, and excitatory transmission without disrupting binding.","evidence":"PDZ2 mutagenesis, time-lapse imaging, surface biotinylation, synaptogenesis assay, and mEPSC recording in mouse neurons","pmids":["30988517"],"confidence":"High","gaps":["How a binding-competent mutant fails at trafficking unresolved","In vivo behavioral consequence not tested"]},{"year":2021,"claim":"Demonstrated the APP–Mint2 interaction is a druggable node, since both a binding-deficient variant and a PTB-targeting peptide inhibitor lower Aβ42 in a neuronal AD model.","evidence":"APP-binding-deficient mutant and cell-permeable PPI inhibitor with Aβ42 ELISA","pmids":["33398998"],"confidence":"Medium","gaps":["Apparent facilitative role for Aβ contrasts with in vivo suppressor phenotype, unresolved","No in vivo efficacy of inhibitor"]},{"year":null,"claim":"It remains unresolved how APBA2 can act as both an in vivo suppressor of amyloidogenic APP processing and a facilitator of Aβ formation in neuronal models, and what physiological cue selects among its conformational, phosphorylation, and cargo-sorting states.","evidence":"Open question synthesizing apparent opposing roles across in vivo knockout and in vitro inhibition studies","pmids":[],"confidence":"Medium","gaps":["Context-dependence of pro- vs anti-amyloidogenic activity undefined","Nuclear function of shuttling Mint2 unknown","Unified regulation of ARM switch, Ser/Src phosphorylation, and cargo choice not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,7,8,11]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9,11]}],"pathway":[{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[7,9,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,12]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[9]}],"complexes":[],"partners":["APP","APLP2","NRXN1","NTRK1","PSEN1","APBA2BP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99767","full_name":"Amyloid-beta A4 precursor protein-binding family A member 2","aliases":["Adapter protein X11beta","Neuron-specific X11L protein","Neuronal Munc18-1-interacting protein 2","Mint-2"],"length_aa":749,"mass_kda":82.5,"function":"Putative function in synaptic vesicle exocytosis by binding to STXBP1, an essential component of the synaptic vesicle exocytotic machinery. May modulate processing of the amyloid-beta precursor protein (APP) and hence formation of APP-beta","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q99767/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APBA2","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/APBA2","total_profiled":1310},"omim":[{"mim_id":"621407","title":"SCHIZOPHRENIA 17; SCZD17","url":"https://www.omim.org/entry/621407"},{"mim_id":"612478","title":"N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3; NECAB3","url":"https://www.omim.org/entry/612478"},{"mim_id":"612027","title":"TRAFFICKING REGULATOR AND SCAFFOLD PROTEIN TAMALIN; TAMALIN","url":"https://www.omim.org/entry/612027"},{"mim_id":"608243","title":"NSE3 HOMOLOG, SMC5-SMC6 COMPLEX COMPONENT; NSMCE3","url":"https://www.omim.org/entry/608243"},{"mim_id":"605104","title":"RNA-BINDING FOX1 HOMOLOG 1; RBFOX1","url":"https://www.omim.org/entry/605104"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Golgi apparatus","reliability":"Enhanced"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":76.5}],"url":"https://www.proteinatlas.org/search/APBA2"},"hgnc":{"alias_symbol":["D15S1518E","LIN-10","MGC:14091","HsT16821"],"prev_symbol":["X11L","MINT2"]},"alphafold":{"accession":"Q99767","domains":[{"cath_id":"2.30.29.30","chopping":"364-416_425-475_496-538","consensus_level":"high","plddt":84.2152,"start":364,"end":538},{"cath_id":"2.30.42.10","chopping":"556-654","consensus_level":"medium","plddt":85.918,"start":556,"end":654},{"cath_id":"2.30.42.10","chopping":"659-742","consensus_level":"medium","plddt":86.4051,"start":659,"end":742}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99767","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99767-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99767-F1-predicted_aligned_error_v6.png","plddt_mean":60.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APBA2","jax_strain_url":"https://www.jax.org/strain/search?query=APBA2"},"sequence":{"accession":"Q99767","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99767.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99767/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99767"}},"corpus_meta":[{"pmid":"17989066","id":"PMC_17989066","title":"Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17989066","citation_count":303,"is_preprint":false},{"pmid":"10336668","id":"PMC_10336668","title":"Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease.","date":"1999","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10336668","citation_count":77,"is_preprint":false},{"pmid":"17032642","id":"PMC_17032642","title":"Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11L-deficient mouse brain.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17032642","citation_count":49,"is_preprint":false},{"pmid":"14970211","id":"PMC_14970211","title":"Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members by X11-like/Mint2 protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14970211","citation_count":43,"is_preprint":false},{"pmid":"10833507","id":"PMC_10833507","title":"Regulation of X11L-dependent amyloid precursor protein metabolism by XB51, a novel X11L-binding protein.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10833507","citation_count":37,"is_preprint":false},{"pmid":"22787047","id":"PMC_22787047","title":"Intracellular amyloid precursor protein sorting and amyloid-β secretion are regulated by Src-mediated phosphorylation of Mint2.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22787047","citation_count":36,"is_preprint":false},{"pmid":"20029827","id":"PMC_20029827","title":"Copy number and sequence variants implicate APBA2 as an autism candidate gene.","date":"2009","source":"Autism research : official journal of the International Society for Autism Research","url":"https://pubmed.ncbi.nlm.nih.gov/20029827","citation_count":31,"is_preprint":false},{"pmid":"11483239","id":"PMC_11483239","title":"Neuronal expression of mint1 and mint2, novel multimodular proteins, in adult murine brain.","date":"2001","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11483239","citation_count":25,"is_preprint":false},{"pmid":"12720574","id":"PMC_12720574","title":"Partial duplication of the APBA2 gene in chromosome 15q13 corresponds to duplicon structures.","date":"2003","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12720574","citation_count":21,"is_preprint":false},{"pmid":"12780348","id":"PMC_12780348","title":"XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12780348","citation_count":20,"is_preprint":false},{"pmid":"19265194","id":"PMC_19265194","title":"Interaction of Mint2 with TrkA is involved in regulation of nerve growth factor-induced neurite outgrowth.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19265194","citation_count":20,"is_preprint":false},{"pmid":"33398998","id":"PMC_33398998","title":"Targeting the APP-Mint2 Protein-Protein Interaction with a Peptide-Based Inhibitor Reduces Amyloid-β Formation.","date":"2021","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/33398998","citation_count":17,"is_preprint":false},{"pmid":"18201694","id":"PMC_18201694","title":"The X11L/X11beta/MINT2 and X11L2/X11gamma/MINT3 scaffold proteins shuttle between the nucleus and cytoplasm.","date":"2007","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18201694","citation_count":14,"is_preprint":false},{"pmid":"34092617","id":"PMC_34092617","title":"Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development.","date":"2021","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/34092617","citation_count":14,"is_preprint":false},{"pmid":"22730553","id":"PMC_22730553","title":"Open-closed motion of Mint2 regulates APP metabolism.","date":"2012","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22730553","citation_count":14,"is_preprint":false},{"pmid":"19222704","id":"PMC_19222704","title":"Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19222704","citation_count":13,"is_preprint":false},{"pmid":"30988517","id":"PMC_30988517","title":"A rare autism-associated MINT2/APBA2 mutation disrupts neurexin trafficking and synaptic function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30988517","citation_count":10,"is_preprint":false},{"pmid":"36749163","id":"PMC_36749163","title":"Comprehensive Peptide Cyclization Examination Yields Optimized APP Scaffolds with Improved Affinity toward Mint2.","date":"2023","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36749163","citation_count":10,"is_preprint":false},{"pmid":"22222501","id":"PMC_22222501","title":"Promoter characterization and genomic organization of the human X11β gene APBA2.","date":"2012","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/22222501","citation_count":7,"is_preprint":false},{"pmid":"29578633","id":"PMC_29578633","title":"Probing the Mint2 Protein-Protein Interaction Network Relevant to the Pathophysiology of Alzheimer's Disease.","date":"2018","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/29578633","citation_count":7,"is_preprint":false},{"pmid":"18007179","id":"PMC_18007179","title":"Reduction of mint-1, mint-2, and APP overexpression in okadaic acid-treated neurons.","date":"2007","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/18007179","citation_count":5,"is_preprint":false},{"pmid":"38575686","id":"PMC_38575686","title":"Molecular dynamics simulations to explore the binding mode between the amyloid-β protein precursor (APP) and adaptor protein Mint2.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38575686","citation_count":4,"is_preprint":false},{"pmid":"20369384","id":"PMC_20369384","title":"Expression and ultrastructural localization of Mint2 in the spinal cord of rats.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/20369384","citation_count":2,"is_preprint":false},{"pmid":"25513723","id":"PMC_25513723","title":"Increased transcriptome sequencing efficiency with modified Mint-2 digestion-ligation protocol.","date":"2014","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25513723","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12321,"output_tokens":3461,"usd":0.044439,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11184,"output_tokens":4339,"usd":0.082198,"stage2_stop_reason":"end_turn"},"total_usd":0.126637,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Mint2/X11L colocalizes with APP in primary cortical neurons and transfected CHO cells; Mint2 reorganizes the subcellular distribution of APP and increases steady-state APP levels when co-expressed, consistent with a role in APP trafficking and metabolism.\",\n      \"method\": \"Immunofluorescence colocalization in primary neurons and transfected CHO cells; co-transfection with subcellular distribution analysis\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, colocalization and co-transfection with distribution assay, no in vitro reconstitution\",\n      \"pmids\": [\"10336668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"XB51, a novel protein, interacts with the amino-terminal domain of X11L (APBA2/Mint2), inhibits the X11L–APP association through a non-competitive mechanism, and abolishes X11L-mediated suppression of beta-amyloid production. Association with X11L redistributes XB51 from a CHAPS-insoluble to a CHAPS-soluble fraction.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation, beta-amyloid production assay, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, functional Aβ assay, and fractionation in a single lab\",\n      \"pmids\": [\"10833507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"hXB51alpha binds X11L to form a tripartite complex (hXB51alpha–X11L–APP) that blocks X11L-mediated suppression of Aβ generation, while hXB51beta binds X11L and inhibits its interaction with APP but suppresses Aβ generation via an X11L-independent mechanism.\",\n      \"method\": \"Co-immunoprecipitation, Aβ production assays, isoform-specific expression constructs\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with functional Aβ assay, single lab, two isoforms tested orthogonally\",\n      \"pmids\": [\"12780348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"X11L (APBA2/Mint2) facilitates JNK-mediated phosphorylation of APP at Thr668 and APLP2 at Thr736 in response to cellular stress, elevating phosphorylation levels. Other X11 family members (X11 and X11L2) did not share this activity.\",\n      \"method\": \"Cell-based phosphorylation assays under osmotic/stress conditions, immunoprecipitation, kinase identification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional phosphorylation assay with multiple substrates and family-member comparisons, single lab\",\n      \"pmids\": [\"14970211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"X11L-deficient (knockout) mice show increased APP C-terminal fragments generated by β-secretase (but not α-secretase) cleavage in the hippocampus, and elevated Aβ levels in aged hippocampus, demonstrating that X11L suppresses amyloidogenic (but not non-amyloidogenic) APP processing in vivo.\",\n      \"method\": \"X11L knockout mouse model, biochemical quantification of APP CTFs and Aβ levels in brain tissue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined molecular phenotype (selective β-secretase pathway), in vivo replicated finding in brain tissue\",\n      \"pmids\": [\"17032642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"X11L (APBA2) and X11L2 shuttle between the cytoplasm and nucleus; nuclear export is CRM1-dependent (blocked by leptomycin B). FLIP analysis confirmed nucleo-cytoplasmic shuttling. A nuclear export signal (NES) was identified in the N-terminus of X11L2; mutation of this NES caused nuclear accumulation.\",\n      \"method\": \"EGFP-fusion localization, leptomycin B treatment, FLIP (fluorescence loss in photobleaching), NES mutagenesis\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with FLIP and pharmacological/mutagenesis validation, single lab\",\n      \"pmids\": [\"18201694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Phosphorylation of X11L at Ser236 and Ser238 within the amino-terminal regulatory region (aa 221–250) enhances its interaction with APP under osmotic stress. Alanyl substitution of either serine abolished the stress-enhanced APP association, indicating that this phosphorylation event, outside the PTB domain, modulates APP binding.\",\n      \"method\": \"Site-directed mutagenesis (Ser→Ala), co-immunoprecipitation under osmotic stress, phosphorylation site identification by mass spectrometry/mutagenesis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with co-IP functional assay, single lab\",\n      \"pmids\": [\"19222704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mint2 interacts with TrkA through its PTB domain in a phosphorylation- and ligand-independent manner. Endogenous Mint2–TrkA interaction was confirmed in rat tissue. Mint2 overexpression inhibited NGF-induced neurite outgrowth in PC12 cells and DRG neurons; Mint2 knockdown facilitated it. Mechanistically, Mint2 promotes TrkA retention in the Golgi, inhibiting surface sorting.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation from rat tissue, immunohistochemistry colocalization, overexpression and siRNA knockdown in PC12 and DRG neurons, Golgi retention assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP in endogenous tissue, gain- and loss-of-function with defined cellular phenotype, Golgi trafficking mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"19265194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structures of APP peptide-free (2.7 Å) and APP peptide-bound (3.3 Å) Mint2 C-terminal mutants revealed that the ARM domain blocks the PTB domain peptide-binding groove in the closed (unbound) state and swings away in the open (APP-bound) state. Mutants locking Mint2 in open or closed conformations dynamically regulated APP metabolism in vitro and in vivo.\",\n      \"method\": \"X-ray crystallography, structure-guided mutagenesis, in vitro APP metabolism assays, in vivo mouse model\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures at near-atomic resolution combined with mutagenesis and both in vitro and in vivo functional validation\",\n      \"pmids\": [\"22730553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Src-mediated phosphorylation of Mint2 regulates APP endocytic sorting: a phosphomimetic Mint2 mutant directed internalized APP toward the autophagic pathway and increased intracellular Aβ accumulation, while the phospho-resistant mutant increased APP recycling to the cell surface and enhanced Aβ42 secretion. APP endocytosis was attenuated in Mint knockout neurons.\",\n      \"method\": \"Mint knockout neurons (endocytosis assay), phosphomimetic/phospho-resistant Mint2 mutants, intracellular trafficking pathway analysis, Aβ measurement\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout plus phosphorylation-site mutagenesis with defined trafficking and Aβ phenotypes, multiple orthogonal approaches\",\n      \"pmids\": [\"22787047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Systematic characterization of the Mint2 protein-protein interaction network showed that APP and presenilin-1 are bona fide Mint2 interaction partners with defined domain specificities. The last two C-terminal amino acids of Mint2 are required for the intramolecular PDZ1 interaction and for Mint2 stability.\",\n      \"method\": \"Peptide binding assays, domain-specific interaction mapping, truncation/deletion analysis\",\n      \"journal\": \"Chembiochem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — systematic PPI mapping with domain specificity data, single lab, biochemical assays\",\n      \"pmids\": [\"29578633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The autism-linked Mint2 N723S mutation (in PDZ2 domain) impairs Nrxn1α stabilization and trafficking to the membrane without affecting direct Nrxn1α binding. The mutant caused more immobile Mint2 puncta in neuronal processes, reduced Nrxn1α at presynaptic terminals, decreased Nrxn-mediated synaptogenesis, and reduced miniature excitatory event frequency.\",\n      \"method\": \"Mutation of conserved PDZ2 residue, time-lapse imaging in primary mouse neurons, surface biotinylation/trafficking assays, synaptogenesis assay, electrophysiology (mEPSC recording)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (imaging, trafficking, synaptogenesis, electrophysiology) in a single study, autism-linked mutation functionally validated\",\n      \"pmids\": [\"30988517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disruption of the APP–Mint2 protein-protein interaction, either by an APP-binding-deficient Mint2 variant or by a cell-permeable peptide inhibitor targeting the Mint2 PTB domain, significantly reduced Aβ42 levels in a neuronal in vitro AD model, demonstrating that Mint2 plays a facilitative role in Aβ formation.\",\n      \"method\": \"APP-binding-deficient Mint2 mutant, cell-permeable PPI inhibitor peptide, Aβ42 ELISA in neuronal AD model cells\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complementary genetic and pharmacological inhibition with defined Aβ readout, single lab\",\n      \"pmids\": [\"33398998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mint proteins (Mint1 and Mint2) are cleaved by calpain upon neurodegeneration induced by okadaic acid (a PP2A inhibitor) in neurons, and their reduction is followed by an increase in APP levels. Calpain inhibitors prevented Mint cleavage and APP overexpression.\",\n      \"method\": \"Okadaic acid neuronal degeneration model, western blot for Mint1/2 and APP, calpain inhibitor treatment\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single biochemical method with pharmacological inhibitor, limited mechanistic depth\",\n      \"pmids\": [\"18007179\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APBA2/Mint2/X11L is a neuronal adaptor protein that binds the cytoplasmic domain of APP via its PTB domain (regulated by an ARM-domain open-closed conformational switch and by Ser236/238 phosphorylation), suppresses amyloidogenic β-secretase cleavage of APP in the hippocampus in vivo, and controls APP endocytic sorting between autophagic and recycling pathways through Src-mediated phosphorylation; it also traffics neurexin-1α to presynaptic terminals via its PDZ2 domain (disrupted by autism-linked N723S mutation), retains TrkA in the Golgi to modulate NGF-induced neurite outgrowth, and is regulated by the binding partner XB51 which can either block or enhance Aβ production depending on its isoform.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"APBA2 (Mint2/X11L) is a neuronal adaptor protein that controls the trafficking and proteolytic processing of the amyloid precursor protein (APP) and other transmembrane partners [#0, #4]. It binds the APP cytoplasmic domain through its PTB domain, an interaction gated by an autoinhibitory ARM domain that occludes the PTB peptide-binding groove in a closed state and swings away upon APP engagement, allowing conformational locking to bidirectionally tune APP metabolism [#8]; APP binding is further enhanced by phosphorylation at Ser236/Ser238 in an N-terminal regulatory region under stress [#6]. In vivo, loss of APBA2 selectively increases β-secretase-derived APP C-terminal fragments and A\\u03b2 in hippocampus, establishing it as a suppressor of amyloidogenic processing [#4], while at the cellular level Src-mediated phosphorylation of Mint2 directs internalized APP between autophagic degradation and surface recycling, with corresponding shifts in A\\u03b2 production [#9]. APBA2 also acts as a presynaptic trafficking factor: through its PDZ2 domain it stabilizes and delivers neurexin-1\\u03b1 to presynaptic terminals, and the autism-linked N723S mutation disrupts this without abolishing direct binding, reducing synaptogenesis and excitatory transmission [#11]. Independently, through its PTB domain it retains TrkA in the Golgi to restrain NGF-induced neurite outgrowth [#7]. Its APP-suppressive activity is itself regulated by the binding partner XB51, whose isoforms either block or enhance A\\u03b2 generation [#1, #2].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established APBA2/Mint2 as a physical and functional regulator of APP rather than an unrelated neuronal protein, by showing it colocalizes with APP and reshapes its distribution and steady-state levels.\",\n      \"evidence\": \"Immunofluorescence colocalization and co-transfection distribution analysis in primary neurons and CHO cells\",\n      \"pmids\": [\"10336668\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define the binding interface or domain\", \"Effect on APP cleavage products not measured\", \"No in vivo confirmation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified XB51 as an upstream regulator of the Mint2–APP axis, showing that the amyloid-suppressing activity of Mint2 is itself modulated by a binding partner.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-IP, A\\u03b2 production assay, and subcellular fractionation\",\n      \"pmids\": [\"10833507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Non-competitive inhibition mechanism not structurally defined\", \"Physiological relevance not tested in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved that XB51 effects on A\\u03b2 are isoform-specific, with hXB51alpha forming a tripartite complex that blocks Mint2 suppression while hXB51beta lowers A\\u03b2 by a Mint2-independent route.\",\n      \"evidence\": \"Co-IP and A\\u03b2 assays with isoform-specific constructs\",\n      \"pmids\": [\"12780348\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mint2-independent mechanism of hXB51beta undefined\", \"No structural basis for tripartite complex\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed Mint2 has a kinase-coupling function specific among X11 family members, facilitating JNK-mediated phosphorylation of APP/APLP2 under stress.\",\n      \"evidence\": \"Cell-based stress phosphorylation assays with family-member comparison\",\n      \"pmids\": [\"14970211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs scaffolded JNK action not separated\", \"Downstream consequence of Thr668 phosphorylation on A\\u03b2 not established here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided the decisive in vivo demonstration that APBA2 selectively suppresses amyloidogenic APP processing, by showing knockout mice accumulate β-secretase CTFs and A\\u03b2 in hippocampus.\",\n      \"evidence\": \"X11L knockout mouse with biochemical quantification of APP CTFs and A\\u03b2 in brain\",\n      \"pmids\": [\"17032642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of pathway selectivity (\\u03b2 vs \\u03b1) not resolved\", \"Cellular trafficking basis not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed APBA2 undergoes CRM1-dependent nucleo-cytoplasmic shuttling, expanding its potential roles beyond cytoplasmic trafficking.\",\n      \"evidence\": \"EGFP-fusion imaging, leptomycin B, FLIP, and NES mutagenesis\",\n      \"pmids\": [\"18201694\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear function of Mint2 unknown\", \"NES mapped directly only for X11L2\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected Mint2 levels to neurodegeneration by showing calpain cleaves it, with consequent APP elevation.\",\n      \"evidence\": \"Okadaic acid degeneration model with western blot and calpain inhibitor\",\n      \"pmids\": [\"18007179\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single biochemical method with pharmacological inhibitor\", \"Calpain cleavage sites not mapped\", \"Causality between Mint loss and APP rise not isolated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a stress-responsive phospho-switch (Ser236/Ser238) outside the PTB domain that tunes Mint2–APP binding strength.\",\n      \"evidence\": \"Ser→Ala mutagenesis with co-IP under osmotic stress\",\n      \"pmids\": [\"19222704\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Responsible kinase not identified\", \"In vivo relevance of these sites untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended Mint2 function beyond APP, showing it retains TrkA in the Golgi via its PTB domain to negatively regulate NGF-induced neurite outgrowth.\",\n      \"evidence\": \"Yeast two-hybrid, endogenous reciprocal co-IP, gain/loss-of-function in PC12 and DRG neurons, Golgi retention assay\",\n      \"pmids\": [\"19265194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single PTB domain selects APP vs TrkA cargo unclear\", \"In vivo neurite/NGF phenotype not shown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided the structural mechanism of Mint2 autoregulation: an ARM domain occludes the PTB groove in a closed state and releases it on APP binding, with conformation-locked mutants bidirectionally controlling APP metabolism.\",\n      \"evidence\": \"X-ray crystallography of free and APP-bound mutants with structure-guided mutagenesis in vitro and in vivo\",\n      \"pmids\": [\"22730553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger that drives the open–closed switch in cells not defined\", \"Relationship of switch to Ser236/238 phosphorylation not integrated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed Src-mediated phosphorylation of Mint2 acts as a sorting switch routing internalized APP between autophagic degradation and recycling, directly coupling Mint2 to A\\u03b2 fate.\",\n      \"evidence\": \"Mint knockout neurons, phosphomimetic and phospho-resistant mutants, trafficking analysis, A\\u03b2 measurement\",\n      \"pmids\": [\"22787047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Src phosphorylation site(s) on Mint2 not fully mapped\", \"Reconciliation with in vivo \\u03b2-secretase suppression role incomplete\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Systematically validated APP and presenilin-1 as domain-specific Mint2 partners and showed the C-terminal residues mediate an intramolecular PDZ1 interaction governing Mint2 stability.\",\n      \"evidence\": \"Peptide binding and domain-mapping with truncation analysis\",\n      \"pmids\": [\"29578633\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of presenilin-1 binding not tested\", \"Stability mechanism not linked to turnover in cells\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked APBA2 directly to autism pathophysiology by showing the PDZ2 N723S mutation impairs neurexin-1\\u03b1 trafficking, synaptogenesis, and excitatory transmission without disrupting binding.\",\n      \"evidence\": \"PDZ2 mutagenesis, time-lapse imaging, surface biotinylation, synaptogenesis assay, and mEPSC recording in mouse neurons\",\n      \"pmids\": [\"30988517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a binding-competent mutant fails at trafficking unresolved\", \"In vivo behavioral consequence not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated the APP–Mint2 interaction is a druggable node, since both a binding-deficient variant and a PTB-targeting peptide inhibitor lower A\\u03b242 in a neuronal AD model.\",\n      \"evidence\": \"APP-binding-deficient mutant and cell-permeable PPI inhibitor with A\\u03b242 ELISA\",\n      \"pmids\": [\"33398998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apparent facilitative role for A\\u03b2 contrasts with in vivo suppressor phenotype, unresolved\", \"No in vivo efficacy of inhibitor\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how APBA2 can act as both an in vivo suppressor of amyloidogenic APP processing and a facilitator of A\\u03b2 formation in neuronal models, and what physiological cue selects among its conformational, phosphorylation, and cargo-sorting states.\",\n      \"evidence\": \"Open question synthesizing apparent opposing roles across in vivo knockout and in vitro inhibition studies\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context-dependence of pro- vs anti-amyloidogenic activity undefined\", \"Nuclear function of shuttling Mint2 unknown\", \"Unified regulation of ARM switch, Ser/Src phosphorylation, and cargo choice not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 7, 8, 11]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [7, 9, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 12]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"APP\", \"APLP2\", \"NRXN1\", \"NTRK1\", \"PSEN1\", \"APBA2BP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}